chrisvoncsefalvay/vaers-outcomes huggingface dataset:
covid test result=Positive; covid test result=Positive; nasal congestion; sneezing runny nose; sneezing runny nose; sinus pressure; dry cough; This is a spontaneous report from a contactable Nurse (patient herself).  This 37-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EL0140), via an unknown route, on 19Dec2020 at 16:15 at single dose for COVID-19 immunisation. Vaccine location was arm left. The patient was not pregnant. The patient was vaccinated at hospital, age at vaccination was 37-year-old. No other vaccine was received in four weeks. No relevant medical history was provided. Relevant concomitant medications included amoxicillin sodium, clavulanate potassium (AUGMENTIN, formulation: tablet) at dose of 875 mg twice daily from an unknown.  Pre-vaccination COVID test was not performed. On 25Dec2020 at 20:00, the patient complained of nasal congestion, sneezing runny nose, sinus pressure, and cough. On 28Dec2020, COVID test Nasal Swab (SOFIA SARS ANTIGEN FIA/QUIDEL) was performed and resulted positive. She was given oral azithromycin 500 mg 1 tab Daily and oral benzonatate (TESSALON PERLES) 1 Capsule three times a day (TID). The symptoms of nasal congestion, sneezing runny nose, sinus pressure, and cough were improving. The outcome of 'COVID test result=Positive' was unknown.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product BNT162B2 to the reported drug ineffective and SARS-CoV-2 test positive cannot be ruled out.
Immediate body aches and fever that led to numbness and tingling in extremities.  Currently, I still have continuous and constant numbness and tingling in my hands and feet and it's been over a month since it began.
contracted COVID; Vaccine did not work out very well for him; Sweats; Fatigue; Throbbing HA; Chills; Muscle pain; Fever of 101.3; A spontaneous report was received from a consumer, concerning a 66-year-old male patient who received Moderna's COVID-19 vaccine and the vaccine did not work out very well for him (lack of effect) and he contracted COVID (COVID-19) and experienced sweats (hyperhidrosis), fatigue, throbbing headache, chills, muscle pain (myalgia) and fever of 101.3 (pyrexia).   The patient's medical history was not provided. Concomitant medications reported included dabigatran etexilate mesilate, blood pressure medication, cholesterol lowering medication and bladder medication.   On 06-Jan-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot number 039k20a) intramuscularly in the right deltoid for prophylaxis of COVID-19 infection.   On 06-Jan-2021, approximately 5 hours after administration of the vaccine shot, patient experienced sweats, fatigue, throbbing headache, chills, muscle pain and fever of 101.3.    On follow-up, the patient reported that the vaccine "did not work out very well" for him and he "contracted COVID" (onset date not reported) and was in the hospital.  Treatment for the events included paracetamol.  Action taken with mRNA-1273 in response to the events were not reported.   The outcome of events, sweats, fatigue, throbbing headache, chills, muscle pain and fever of 101.3 were considered not resolved at the time of this report.  The outcome of COVID was unknown.  Follow-up received on 01 Mar 2021 included addition of events.; Reporter's Comments: Based on the natural history of COVID-19, and the established information about the mRNA-1273 vaccine, a causal association between the event of COVID and the product use is assessed as unlikely.  Th event was most likely pre-existing. The other events are assessed as symptoms of the COVID-19.  However, fatigue, headache, chills, muscle pain  and fever are consistent with the known safety profile of the vaccine and a causal relationship cannot be excluded.
1530: arrived for appointment 1545: vaccinated, observed, released 1600: drove back up to site w symptoms after talking to med greeter 1605: we called 911 1614: ambulance arrives 1648: patient departed in POV -fullness in throat -wheezing -hives on chest
Information has been received from a nurse concerning a female (age not reported) who on 20-JUL-2007 was vaccinated with Gardasil (lot # unknown). On 20-JUL-2007 the patient fainted after receiving Gardasil. Medical attention was sought. At the time of reporting the patient recovered. No additional information was provided. This is one of two reports from the same source. Additional information has been requested.
Fever chills Aches started at 10pm on 9-10-2018. Lasted the night and started to improve the next morning. Patient missed one day of work. Patient also complained of frequent urination on the morning of 9-12-18. And feels that it may be related, but was not sure. Patient reports that all symptoms have resolved by 9-13-18.
On 01/11/21 in the mid afternoon I developed a runny nose and then later felt like I couldn?t take a deep breath. I used albuterol inhaler, two puffs but after a few minutes did not improve. Went to an Urgent Care clinic and explained what had happened after the first vaccine. I received 60 mg oral prednisone and an albuterol breathing treatment via nebulizer.
On 3/17 Developed a bad  itchy red full body rash. Was given course of Prednisone and Antihistamines Rx
Area of vaccine administration turned red, swollen, hot and itching the day after of vaccine was administered. Patient come to pharmacy to indicated what was happening 7 days after vaccine was administered. I recommended patient to visit the doctor office. Doctor prescribed Cefadroxil 500 mg twice a day and DERMAGESIC lotion. Today 03/24/2019 patient indicated me that the area is as yesterday and she don't see any improvement. Doctor said that the follow appointment will be two days after the first dose of antibiotics.
Left deltoid my region day after injection. Left arm forearm paresthesias 2 weeks following injection - possible early brachial neuritis.
Experienced Double Vision about 30 minutes after injection. Cleared within 20 minutes.  After 36 hours: injection site tenderness, swelling, (no redness)
I woke up lightheaded and dizzy. I rested throughout the day. Dizziness and lightheaded had resolved by the next day.
Pt had received 1st dose of Moderna vaccine on 03/01/2021.  Was then administered Pfizer vaccine as 2nd dose on 04/13/2021.
breaking out on hives on her face, neck and chest. She saw a doctor and he told her it was anaphylactic reaction; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ANAPHYLACTIC REACTION (breaking out on hives on her face, neck and chest. She saw a doctor and he told her it was anaphylactic reaction) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     The patient's past medical history included Hives. Concomitant products included DROSPIRENONE, ETHINYLESTRADIOL (GIANVI) for an unknown indication.  She had never had an allergic reaction to any vaccination on the past. She does have a skin condition so she gets hives easily and similar hives when taking some beers.  On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced ANAPHYLACTIC REACTION (breaking out on hives on her face, neck and chest. She saw a doctor and he told her it was anaphylactic reaction) (seriousness criterion medically significant). At the time of the report, ANAPHYLACTIC REACTION (breaking out on hives on her face, neck and chest. She saw a doctor and he told her it was anaphylactic reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication reported  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Tingling tongue, getting worse, flushing and BP up from 138/82 to 172/112 within 40 minutes of the dose.
This case was reported by a healthcare professional (office manager) via sales representative and described the occurrence of pertussis in a subject of unspecified age and gender who was vaccinated with BOOSTRIX (GlaxoSmithKline). On 2 April 2012 the subject received a dose of BOOSTRIX (unknown details). At an unspecified time after vaccination with BOOSTRIX, the subject experienced pertussis and vaccination failure. This case was associated with a product complaint as the physician questioned the lot number. No further details were provided by the healthcare professional. This case was assessed as medically serious by GSK. At the time of reporting the outcome of the events were unspecified. The healthcare professional reported another case with BOOSTRIX. See case A1047577A for details on the other case. Quality Assurance results and safety statement was received 06 November 2013. A safety assessment was requested, an evaluation was performed and the conclusion shows that: considering the currently available data for batch number AC52B077AA (and family), it is unlikely that the reported events are linked to a manufacturing issue. No further investigation is required. GlaxoSmithKline Biologicals considers this complaint as unsubstantiated.
Pt reported a headache, abdominal pain, nausea, muscle aches and shivering lasting 12 to 24 hours.
4 hours after recieving the vaccine,  I began to have pain and stiffness in the L shoulder joint. By the evening of the day of administration this progressed to the point that I had severe pain in the joint, could not move the arm at the shoulder joint at all and had to support the L arm using my Right hand to help limit the pain.  I ws unable to sleep that night due to the severity of the pain and inability to find a comfortable position for the arm and shoulder.  There was no swelling or indurationin the deltoid or other muscles of the arm.  For the next 2 days I continued to have very limited shoulder ROM and needed to support the arm for pain control .   Pain and loss of ROM slowly improved over the next 2 weeks.  Full use of shoulder took 2 months.  ( I did home ROM excersizes)  There is now a tendon-type click in that shoulder with motion.  I am an internist myself and have no doubt in my mind that I had an accidental  interarticular injection with SIRVA syndrome.  i didi report this to the medical office
Patient received flu vaccine first. Then I gave her the BOOSTRIX vaccine. After pulling out needle. She immediately fainted in chair. She came to w/in approximately 5-7 seconds and had no further incidents.
A report has been received from a Health Professional concerning a 31 year old, Female subject, who had been receiving Nasal FLUMIST (INTRANASAL). FLUMIST (INTRANASAL) started on an unknown date. The patient got FLUMIST on parent hands and parent's hand became irritated which started on 29-Oct-2014. The outcome of the event of HAND IRRITATION and FLUMIST GOT ON PARENT HANDS is unknown. The report was considered to be non-serious.
This spontaneous report was received from a registered nurse and refers to a 18 month old patient of an unknown gender. The patient's pertinent medical history, drug reactions and allergies were not reported. Information regarding concomitant therapies was not provided. On 20-NOV-2017, the patient was vaccinated with PROQUAD (unknown albumin status) lot # N014759 for prophylaxis (dose, route of administration, expiration date and anatomical location were not reported) and VARIVAX lot# M048200 with an expiration date 07-DEC-2018 (dose, route of administration and anatomical location were not reported). No adverse effects was reported. This is one of two reports received from the same reporter. Sender's Comments: US-009507513-1712USA008472.
Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 22-JAN-2015, the patient was vaccinated with improperly stored VAQTA (strength: 25/0.5 (unit unspecified), lot # K005323 with expiration date of 10-FEB-2017; dosage and route unspecified). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
shortly after vaccine , patient fainted and fell off his chair; got a large bimp on forehead, emt arrived and patient left with rescue
Seizure; patient began walking in circles, was unfocused, would not make eye contact, drooled, breathing changed, heart raced, fingers were stroking fabric, does not remember any of this.
Erythema Multiform and erythema, swelling, pain at injection site. Treatment: Diphenhydramine.
Muscle aches, severe chills, shaking/teeth chattering. Head felt ?off? all day. 10 days later diarrhea for several days.
Severe headache developed the following day. Bad enough that I could not easily hold a conversation and I could not safely drive home from work without first taking over the counter painkillers and relaxing for half an hour. The headache lasted for another 2 days or so and still required painkillers to help.
Pt stated she got a rash around her eyes 45 minutes after receiving the flu vaccine. She took Benadryl orally and Benadryl CR topically.
There was pain, not severe, warm heat, extra warm and swelling. The heat has not resided, it's still there. The swelling has decreased a lot, and the itching has decreased as well. I spoke to the pharmacy and the pharmacist advised I contact you.
vaccine was given to a child 2 weeks after expiration; This spontaneous report was received from a nurse and refers to a child of an unknown gender. Information regarding the patient's drug reactions or allergies, concomitant therapies and pertinent medical history was not provided. On an unknown date ,the patient was vaccinated with measles (+) mumps (+) rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) for prophylaxis, 2 weeks after vaccine expiry date (formulation, strength, dose number, concentration, route of administration, frequency, lot # and exact expiry date were not reported). The nurse asked when to perform a titer test. No product quality complaint (PQC) was reported.
After 12 hours and for the first 24 hours, exhaustion, headache, soreness at vaccination site in left arm and in lymph nodes under left arm and low grade fever.  On morning of 3-11-21, about 36 hours later, redness (rash?) at vaccination site, and lymph nodes under my left arm are swollen but not painful.  Remaining is some residual tiredness but no headache and feel otherwise good.
The patient presented with erythema multiforme on bilateral palms and lower extremities, which started a little over the week post the 2nd dose of the COVID vaccine. The patient reports that the rash was painful at the beginning but it's better now. No other side effects reported.
PATIENT NOTICED AREA ON ARM WHERE VACCINE WAS ADMINISTERED "A HUGE AREA THAT WAS TENDER, HOT, AND BUBBLY." THE PATIENT WENT TO THE DOCTOR THE NEXT DAY AND WAS DIAGNOSED WITH SHINGLES.
Had chills about 3 hours later, a fever, very tired,  on 10/21 started having lower back pain. Had a hard time walking, felt like I couldn't walk, and it took a lot of focus to get my feet to move the way I wanted them to.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date'; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date'; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date') and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date') in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066h21a) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2022 at 3:46 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 25-Mar-2022 at 3:46 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date'). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date'). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date') and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date') outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported. The patient received vaccine past its 30 day expiry date on 25-Mar-2022 at 15:46:56 , booster dose. Vaccine went into 2 to 8 degree Celsius thaw state on about 24-Dec-2021. The vaccine was administered up until its manufacturing expiry date of 04-Apr-2022.  No treatment information was provided by the reporter.   This case was linked to MOD-2022-542869 (Patient Link).
1 to 2 minutes after injection began having heart palpitations and PVCs. Lasted 1 hour No treatment was required
Pain, lump, erythema around area of PNEUMOVAX that spread over 48 hours up her arm before resolving.
Hot all over/bottom of feet were on fire; Left ear popped; Felt very sick/felt bad; Lethargic; Vomiting; Severe headache; Fever; Chills; A spontaneous report was received from a female patient who received Moderna's COVID-19 Vaccine and experienced hot all over/bottom of feet were on fire (feeling hot), felt very sick/felt bad (malaise), left ear popped (ear discomfort), severe headache, was lethargic, vomiting, fever (pyrexia), and chills.  The patient's reported medical history included COVID-19 (April 2020).  A COVID antibody test on 24 Nov 2020 showed she still had antibodies.  No relevant concomitant medications were reported.   On 31 Dec 2020, the patient received the first of two planned doses of mRNA-1273 intramuscularly for COVID-19 for infection prophylaxis.  On 01 Jan 2021, the patient was hot all over, felt very sick, her left ear popped, she had a severe headache, she was lethargic, was vomiting, had a fever and chills. She stated that her body temperature was 101.1.  On 02 Jan 2021, the patient felt bad, her temperature was 103.0, she had a severe headache, and the bottom of her feet were on fire. She also reported that she had lethargy, chills, and stated, "it felt like I had COVID again."   On 02 Jan 2021, the patient did not vomit and she felt much better, but was still lethargic.   Treatment for the events was not reported.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the event, vomiting, was considered resolved on an unknown date January 2020. The outcome of the events, hot all over/bottom of feet were on fire, felt very sick/felt bad, left ear popped, severe headache, fever, and chills were resolving.  The event of lethargic was considered not resolved at the time of this report.; Reporter's Comments: This case concerns a female who experienced with NS events of unexpected malaise, lethargy, feeling hot, ear discomfort and expected fever, chills, headache, vomiting.  Event onset occurred on Day 2 after the first dose of mRNA-1273. Treatment not reported. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
lump that feels like a knot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (lump that feels like a knot) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 01SM201A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE MASS (lump that feels like a knot). At the time of the report, VACCINATION SITE MASS (lump that feels like a knot) outcome was unknown.            No concomitant medication details was reported. No treatment medication details was reported.
realized that the powder was not dissolved completely; realized that the powder was not dissolved completely; This case was reported by a pharmacist and described the occurrence of inappropriate preparation of medication in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th December 2020, the patient received Shingrix. On 29th December 2020, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were reported as follows: The age at vaccination was not reported. The reporter stated that, they administered Shingrix to the patient and then realized that the powder was not dissolved completely, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter consented to follow up. No further information provided.  The reporter did not provide address as she mentioned that she was travelling and did not have a specific address. She did not have patient's details or vaccine's details at the moment as she was driving. This case has been linked to US2020258487, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020258487:same reporter
Dizziness, nausea for 2-3hrs starting 26 hours after vaccine, then projectile vomiting approximately 28 hours after. 48hrs later still nauseated, dizzy and headache